Department of Dermatology

Can checkpoint inhibitor therapy improve response to chemotherapy? (2018) Kirchberger MC, Schilling B, Haferkamp S, Boßerhoff AK, Schuler G, Heinzerling L Journal article Type IV contact allergies in the food processing industry: an update (2018) Bauer A, Schubert S, Geier J, Mahler V Journal article Systemische Therapien des Ulcus cruris (2018) Dissemond J, Goerge T, Kroeger K, Funke-Lorenz C, Reich-Schupke S, Erfurt-Berge C Journal article The p.Arg435His Variation of IgG3 With High Affinity to FcRn Is Associated With Susceptibility for Pemphigus Vulgaris-Analysis of Four Different Ethnic Cohorts (2018) Recke A, Konitzer S, Lemcke S, Freitag M, Sommer NM, Abdelhady M, Amoli MM, et al. Journal article The Generation of CAR-Transfected Natural Killer T Cells for the Immunotherapy of Melanoma (2018) Simon B, Wiesinger M, Maerz J, Wistuba-Hamprecht K, Weide B, Schuler-Thurner B, Schuler G, et al. Journal article The simultaneous siRNA-mediated downregulation of PD-1 and CTLA-4 to improve CAR-T cell immunotherapy of melanoma (2018) Simon B, Harrer D, Schuler-Thurner B, Dörrie J, Schaft N, Schuler G, Uslu U Conference contribution Understanding microRNA-mediated immunogenicity of dendritic cells using an integrative approach (2018) Lai X, Dreyer F, Jaitly T, Cantone M, Gerer KF, Schuler G, Dörrie J, et al. Conference contribution Managing toxicities of immunotherapies - a side effect register for rare and severe side effects of checkpoint Inhibitor therapy (2018) Heinzerling L, Schuler G Conference contribution Effective anti-programmed death-1 therapy in a SUFU-mutated patient with Gorlin-Goltz syndrome (2018) Moreira A, Kirchberger MC, Toussaint F, Erdmann M, Schuler G, Heinzerling L Journal article Genital ulcers as diagnostic clue for acute myeloid leukaemia (2018) Schröder S, Krause S, Erfurt-Berge C Journal article